Drug re-importation has long been an issue in American politics. It's not surprising, therefore, that the Senate once again is considering whether U.S. consumers should be able to purchase medicines originally manufactured in the United States, exported abroad, then later re-imported back into the country.

---------------------------------------------------------------------

You must be an online subscriber to view this story.

Username or e-mail address: *

You may login with either your assigned username or your e-mail address.

Password: *

The password field is case sensitive.

Secure Login

Not an online subscriber yet? Sign Up Here
Purchase this online single issue Purchase Now
Note: You must have cookies enabled to use subscription service
Member Functions:
Forgot your password?